Abstract
Rapid diagnosis of active Mycobacterium tuberculosis (Mtb) infection remains a clinical and laboratory challenge. We have analyzed the cytokine profile (interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α) and interleukin-2 (IL-2)) of Mtb-specific T cells by polychromatic flow cytometry. We studied Mtb-specific CD4+ T cell responses in subjects with latent Mtb infection and active tuberculosis disease. The results showed substantial increase in the proportion of single-positive TNF-α Mtb-specific CD4+ T cells in subjects with active disease, and this parameter was the strongest predictor of diagnosis of active disease versus latent infection. We validated the use of this parameter in a cohort of 101 subjects with tuberculosis diagnosis unknown to the investigator. The sensitivity and specificity of the flow cytometry–based assay were 67% and 92%, respectively, the positive predictive value was 80% and the negative predictive value was 92.4%. Therefore, the proportion of single-positive TNF-α Mtb-specific CD4+ T cells is a new tool for the rapid diagnosis of active tuberculosis disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kaufmann, S.H. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1, 20–30 (2001).
Flynn, J.L. & Chan, J. Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93–129 (2001).
Lalvani, A. et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357, 2017–2021 (2001).
Ewer, K. et al. Comparison of T cell–based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361, 1168–1173 (2003).
Meier, T., Eulenbruch, H.P., Wrighton-Smith, P., Enders, G. & Regnath, T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur. J. Clin. Microbiol. Infect. Dis. 24, 529–536 (2005).
Jasmer, R.M., Nahid, P. & Hopewell, P.C. Clinical practice. Latent tuberculosis infection. N. Engl. J. Med. 347, 1860–1866 (2002).
Betts, M.R. et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107, 4781–4789 (2006).
Harari, A. et al. Functional signatures of protective antiviral T cell immunity in human virus infections. Immunol. Rev. 211, 236–254 (2006).
Pantaleo, G. & Harari, A. Functional signatures in antiviral T cell immunity for monitoring virus-associated diseases. Nat. Rev. Immunol. 6, 417–423 (2006).
Pantaleo, G. & Koup, R.A. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat. Med. 10, 806–810 (2004).
Day, C.L. et al. Detection of polyfunctional Mycobacterium tuberculosis–specific T cells and association with viral load in HIV-1–infected persons. J. Infect. Dis. 197, 990–999 (2008).
Sutherland, J.S., Adetifa, I.M., Hill, P.C., Adegbola, R.A. & Ota, M.O. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur. J. Immunol. 39, 723–729 (2009).
Flynn, J.L. et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2, 561–572 (1995).
Feldmann, M. & Maini, R.N. Anti-TNF α therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19, 163–196 (2001).
Maini, R. et al. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 354, 1932–1939 (1999).
Berry, M.P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973–977 (2010).
Lamoreaux, L., Roederer, M. & Koup, R. Intracellular cytokine optimization and standard operating procedure. Nat. Protoc. 1, 1507–1516 (2006).
Harari, A. et al. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional and long-lasting T cell responses. J. Exp. Med. 205, 63–77 (2008).
Zimmerli, S.C. et al. HIV-1-specific IFN-γ/IL-2–secreting CD8 T cells support CD4-independent proliferation of HIV-1–specific CD8 T cells. Proc. Natl. Acad. Sci. USA 102, 7239–7244 (2005).
Griner, P.F., Mayewski, R.J., Mushlin, A.I. & Greenland, P. Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann. Intern. Med. 94, 557–592 (1981).
Metz, C.E. Basic principles of ROC analysis. Semin. Nucl. Med. 8, 283–298 (1978).
Zweig, M.H. & Campbell, G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39, 561–577 (1993).
Acknowledgements
This research was partially conducted as part of the Vaccine Immune Monitoring Consortium under the Collaboration for AIDS Vaccine Discovery with support from the Bill & Melinda Gates Foundation. Furthermore, we thank N. Rettby, D. Bonnet and K. Ellefsen Lavoie for logistic coordination. We also thank many additional members of the South African Tuberculosis Vaccine Initiative team who helped with enrollment and evaluation of participants and, finally, the participants themselves.
Author information
Authors and Affiliations
Contributions
A.H. designed the study, performed the analyses and wrote the manuscript; V.R., F.B.E. and M.P. generated data and performed analyses; J.M.S., L.P.N., M.C., T.C., C.L.B., C.L.D. and W.A.H. recruited study participants; K.J. performed analyses; M.F. performed the statistical analyses; P.-A.B. contributed to the design of the study, performed analyses and wrote the manuscript; G.P. designed the study, supervised the analyses and wrote the paper. All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Tables 1 and 2 and Supplementary Figures 1–7 (PDF 389 kb)
Rights and permissions
About this article
Cite this article
Harari, A., Rozot, V., Enders, F. et al. Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 17, 372–376 (2011). https://doi.org/10.1038/nm.2299
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2299
This article is cited by
-
Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
BMC Immunology (2023)
-
Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity
Scientific Reports (2023)
-
Evaluation of IFIT3 and ORM1 as Biomarkers for Discriminating Active Tuberculosis from Latent Infection
Current Medical Science (2022)
-
HLA alleles, disease severity, and age associate with T-cell responses following infection with SARS-CoV-2
Communications Biology (2022)
-
Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study
BMC Infectious Diseases (2021)